Viking Thera (VKTX)

Mar 26, 2025, 7:05 AM EDT - 7 days ago

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Mar 13, 2025, 1:12 PM EDT - 20 days ago

Viking Therapeutics: No Buyout Needed Now

Mar 12, 2025, 11:54 AM EDT - 21 days ago

Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in.

Mar 12, 2025, 7:07 AM EDT - 21 days ago

Viking Therapeutics Is Ready For A Standalone Future

Mar 11, 2025, 12:43 PM EDT - 22 days ago

Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade)

Mar 11, 2025, 7:03 AM EDT - 22 days ago

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

Mar 10, 2025, 11:18 PM EDT - 23 days ago

​Viking Therapeutics: Signs Of Insufficient Differentiation In Obesity Treatment​ (Rating Downgrade)

Mar 6, 2025, 3:30 PM EST - 27 days ago

Stock Picks From Seeking Alpha's February 2025 New Analysts

ADM AN BKSY COIN CRNT DAVE DSI

Mar 4, 2025, 4:05 PM EST - 4 weeks ago

Viking Therapeutics to Participate at Upcoming Investor Conferences

Feb 24, 2025, 8:16 PM EST - 5 weeks ago

Viking Therapeutics: Development Of VK2735 Continues, Buyout Or Not

Feb 5, 2025, 7:21 PM EST - 2 months ago

Viking Therapeutics, Inc. (VKTX) Q4 2024 Earnings Conference Call Transcript

Feb 5, 2025, 4:05 PM EST - 2 months ago

Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update

Feb 5, 2025, 3:34 AM EST - 2 months ago

Viking Therapeutics: Why The Oral VK2735 Phase 2 Readout Could Send The Stock Soaring

Jan 29, 2025, 4:05 PM EST - 2 months ago

Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025

Jan 23, 2025, 9:15 AM EST - 2 months ago

Viking Therapeutics: Investors Meeting Reality Of The Obesity Market

Jan 23, 2025, 7:38 AM EST - 2 months ago

Why this Weight-Loss Drug Stock Could Gain 200%

Jan 22, 2025, 6:46 AM EST - 2 months ago

Top 3 Health Care Stocks That Could Blast Off This Quarter

RDNT VERA

Jan 21, 2025, 3:04 PM EST - 2 months ago

What's next for Viking Therapeutics? Here's how the company can scale up.

Jan 13, 2025, 12:56 PM EST - 2 months ago

3 Oversold Biotech Names

AVDL FOLD JAZZ XBI

Jan 8, 2025, 7:03 AM EST - 3 months ago

Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

Jan 6, 2025, 4:05 PM EST - 3 months ago

Viking Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 6, 2025, 2:53 PM EST - 3 months ago

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst

GPCR

Dec 19, 2024, 11:55 AM EST - 3 months ago

Viking Therapeutics: Competition Fears Are Exaggerated

Dec 19, 2024, 10:30 AM EST - 3 months ago

Viking Therapeutics: Holiday Gift

Dec 18, 2024, 1:12 PM EST - 3 months ago

What's Going On With Viking Therapeutics Stock On Wednesday?

Dec 5, 2024, 12:33 PM EST - 4 months ago

Viking Stock Pops, Then Drops On Latest Obesity / MASH Data - Why I'm Still Bullish

Nov 29, 2024, 8:42 AM EST - 4 months ago

Viking Therapeutics Stock On Brink Of Death Cross As Weight Loss Hype Loses Momentum

Nov 26, 2024, 10:09 AM EST - 4 months ago

Biden Proposes Medicare, Medicaid Access For Popular Weight-Loss Drugs

AMGN LLY NVO

Nov 20, 2024, 1:26 PM EST - 4 months ago

Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs

Nov 20, 2024, 12:06 PM EST - 4 months ago

Viking Therapeutics is more than just a weight-loss stock, and that's drawing cheers

Nov 19, 2024, 4:03 PM EST - 4 months ago

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Nov 18, 2024, 10:00 PM EST - 4 months ago

RFK Jr.'s HHS nomination sparks concern over pharma stocks

AMGN AZN LLY NVO XLV

Nov 15, 2024, 11:19 AM EST - 4 months ago

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

AMGN LLY NVO TERN

Nov 12, 2024, 4:05 PM EST - 5 months ago

Viking Therapeutics to Present Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024

Nov 8, 2024, 12:54 PM EST - 5 months ago

Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca

AZN

Nov 4, 2024, 6:31 PM EST - 5 months ago

Viking Therapeutics soars then drops on obesity data

Nov 4, 2024, 1:05 PM EST - 5 months ago

Viking Therapeutics' Hot Stock Slips After Latest Obesity Drug Trial Results

Nov 4, 2024, 12:10 PM EST - 5 months ago

Dow Jones, S&P 500 slip ahead of US elections; NVIDIA, Viking Therapeutics rise while Talen Energy declines

TLN

Nov 4, 2024, 11:20 AM EST - 5 months ago

Viking Therapeutics: Too Much Excitement Around Oral VK2735, Even If It Met High Expectations

Nov 4, 2024, 11:07 AM EST - 5 months ago

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data